Japan's pharmaceutical industry, recognized as a global innovation leader, is navigating simultaneous pressure from shifting demand patterns, supply chain vulnerabilities, and accelerating digital disruption. A new framework identifies eight operational priorities designed to help the sector maintain its competitive position rather than cede ground to faster-moving rivals. The priorities address structural weaknesses that have become harder to ignore: demand volatility has exposed forecasting gaps, while supply dependencies have raised resilience concerns across the production base. Digital disruption is compressing timelines for decision-making and manufacturing adaptation. The eight-priority framework functions as an operational roadmap, targeting areas where process reform and technology adoption can reduce margin erosion and improve throughput. For investors and operators tracking Japan's pharma sector, the key variable is execution speed, how quickly companies translate strategic priorities into measurable operational change amid a regulatory and demographic environment that continues to shift.
Flipkart will launch a food delivery pilot in Bengaluru by mid-August, charging restaurants a 10-11% commission compared to the 25-35% levied by Swiggy and Zomato. The move targets growing restaurant discontent with incumbent platforms and aims to drive daily engagement across Flipkart's 500 million registered users.
Maruti Suzuki crossed two lakh domestic units in July 2026 for the first time, recording 42.4% year-on-year growth. Total sales including exports and OEM supplies reached 2,41,421 units, with all passenger vehicle segments posting gains.
Air India's net loss more than doubled to ₹22,238 crore in FY26, prompting Tata Sons chairman N Chandrasekaran to extend the Vihaan.AI turnaround timeline from five years to as long as a decade.
UpGrad's all-stock acquisition of Unacademy, valued at Rs 1,955 crore, is set to close within three weeks after CCI clearance and near-complete investor sign-offs. The deal combines upGrad's upskilling business with Unacademy's test prep and medical education platforms, with Gaurav Munjal staying on as CEO.
